Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market Clinical Follow-up Study to Evaluate the Safety and Performance of the HydroMARK® Breast Biopsy Site Marker

NCT04622696 is registered in ClinicalTrials.gov with Devicor Medical Products, Inc. as lead sponsor.

NCT NCT04622696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04622696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market Clinical Follow-up Study to Evaluate the Safety and Performance of the HydroMARK® Breast Biopsy Site Marker
Lead sponsor
Devicor Medical Products, Inc.
Phase
Observational
Overall status
Completed
Start date
February 16, 2021
Completion date
August 7, 2023
Enrollment
730 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer